Subscribe To
Astrazeneca (azn) set to acquire cincor pharma for $1.3b
AstraZeneca's (AZN) CinCor Pharma buyout is going to add blood pressure drug baxdrostat to its cardiore...
January 10, 2023, 9:47 am
Medtronic plc (mdt) j.p. morgan 41st annual healthcare conference
Medtronic plc (NYSE:MDT ) J.P. Morgan 41st Annual Healthcare Conference January 9, 2023 11:15 AM ET Company Participants Geoff Martha - Chairman and C...
January 9, 2023, 2:33 pm
Astrazeneca to acquire cincor for us$1.8bn
AstraZeneca PLC (LSE:AZN) has announced it will acquire US-based biopharmaceutical firm CinCor for approximately US$1.8bn in an effort to boost its tr...
January 9, 2023, 7:09 am
Astrazeneca to buy cincor pharma in $1.8 billion deal
AstraZeneca said the deal, expected to close in the first quarter of 2023, will bolster its cardiorenal...
January 9, 2023, 4:32 am
Astrazeneca will buy u.s.-based cincor for cardiorenal asset
AstraZeneca PLC said Monday that it has agreed to buy CinCor Pharma, Inc., acquiring global rights to the latter's baxdrostat ...
January 9, 2023, 2:29 am
Nuwellis appoints dr. john jefferies as chief medical officer
Dr. Jefferies brings over two decades of cardiology and heart failure expertise to Nuwellis as the Comp...
January 5, 2023, 7:40 pm
Reviva pharmaceuticals announces letter to shareholders
CUPERTINO, Calif., Jan. 04, 2023 (GLOBE NEWSWIRE) — Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a clin...
January 4, 2023, 11:00 am
2023 a big year for testosterone: abbvie and ani pharmaceuticals best positioned to benefit
Results from three major testosterone trials expected in 2023, including the largest testosterone cardio...
January 1, 2023, 8:29 am
Apple watches violate alivecor patents but import ban on hold -u.s. itc
Apple Inc's Apple Watches with an electrocardiogram (ECG) function infringe patents belonging to medica...
December 22, 2022, 5:34 pm
Biocardia letter to shareholders
SUNNYVALE, Calif., Dec. 22, 2022 (GLOBE NEWSWIRE) — BioCardia, Inc. (Nasdaq: BCDA), a clinical-stage developer of cellular and cell-derived therapeu...
December 22, 2022, 12:00 pm
Auckland woman with terminal heart failure can’t get cardiologist appointment
Gemma Ball was given a year to live. Now she’s questioning her diagnosis – but can’t see a specialist to answer those questions. Read Full Story...
December 21, 2022, 10:14 pm
cardiol therapeutics kicks off a multi-center phase ii pilot study of cardiolrx for the treatment of recurrent pericarditis
cardiol Therapeutics (TSX:CRDL, NASDAQ:CRDL) Inc revealed that it had initiated a Phase II open-label p...
December 12, 2022, 11:59 am
Alnylam (alny) seeks to expand onpattro label in cardiomyopathy
Alnylam (ALNY) initiates label expansion filing with FDA for Onpattro to treat cardiomyopathy in patien...
December 9, 2022, 12:48 pm
Burgeoning prevalence of cardiovascular diseases to push drainage bottles sales past us$ 1.2 billion by 2032
Drainage Bottles Market to Register 8.5% CAGR Amid Increasing Number of Road Accidents Worldwide Rockville, Dec. 08, 2022 (GLOBE NEWSWIRE) — The dra...
December 8, 2022, 4:00 pm
Silence therapeutics: excellent data in a cardiovascular indication
SLN is a gene silencing therapy developer. SLN produced excellent data from its lead candidate....
December 6, 2022, 2:19 am
Amgen inc. (amgn) world congress on insulin resistance, diabetes and cardiovascular disease conference (transcript)
Amgen Inc. (NASDAQ:AMGN ) World Congress on Insulin Resistance, Diabetes and cardiovascular Disease Con...
December 5, 2022, 12:55 pm
Medtronic plc (mdt) q2 2023 earnings call transcript
Medtronic plc (NYSE:MDT ) Q2 2023 Earnings Conference Call November 22, 2022 8:00 AM ET Company Participants Ryan Weispfenning - Vice President and He...
November 22, 2022, 12:55 pm
cardio diagnostics to present at the benchmark company's upcoming discovery one-on-one investor conference
CHICAGO--( BUSINESS WIRE )--cardio D iagnostics Holdings Inc (Nasdaq: CDIO) today announced it would be...
November 21, 2022, 8:00 am
Amgen, inc. (amgn) american heart association (aha) scientific sessions 2022 transcript
Amgen, Inc. (NASDAQ:AMGN ) American Heart Association (AHA) Scientific Sessions 2022 November 8, 2022 4:30 AM ET Company Participants David Reese - EV...
November 12, 2022, 8:52 pm
Verve therapeutics to participate in upcoming investor conferences
BOSTON, Nov. 11, 2022 (GLOBE NEWSWIRE) — Verve Therapeutics, a clinical-stage biotechnology company pioneering a new approach to the care of ...
November 11, 2022, 11:30 am